The acquisition complements Novozymes’ existing business in the pulp & paper, textile, grain-processing and animal feed industries.
The deal provides Novozymes with all commercial rights to Iogen Bio-Products’ existing product portfolio, pipeline, facilities and know-how.
Novozymes acquires all of Iogen Corporation’s industrial enzyme business. The acquisition does not include the purchase of assets that relate to Iogen Corporation’s bioenergy process technologies.
Andrew Fordyce, vice president of global enzyme sales and customer solutions at Novozymes, said: “Iogen Bio-Products is a good fit for Novozymes.
“We get a number of products that complement our existing product portfolio and welcome a talented group of employees who are very good at developing and producing industrial enzymes.”
Source: Novozymes
© FoodBev Media Ltd 2024